<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:arxiv="http://arxiv.org/schemas/atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>q-bio.TO updates on arXiv.org</title>
    <link>http://rss.arxiv.org/rss/q-bio.TO</link>
    <description>q-bio.TO updates on the arXiv.org e-print archive.</description>
    <atom:link href="http://rss.arxiv.org/rss/q-bio.TO" rel="self" type="application/rss+xml"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <language>en-us</language>
    <lastBuildDate>Fri, 21 Nov 2025 05:08:33 +0000</lastBuildDate>
    <managingEditor>rss-help@arxiv.org</managingEditor>
    <pubDate>Fri, 21 Nov 2025 00:00:00 -0500</pubDate>
    <skipDays>
      <day>Saturday</day>
      <day>Sunday</day>
    </skipDays>
    <item>
      <title>SAM2S: Segment Anything in Surgical Videos via Semantic Long-term Tracking</title>
      <link>https://arxiv.org/abs/2511.16618</link>
      <description>arXiv:2511.16618v1 Announce Type: cross 
Abstract: Surgical video segmentation is crucial for computer-assisted surgery, enabling precise localization and tracking of instruments and tissues. Interactive Video Object Segmentation (iVOS) models such as Segment Anything Model 2 (SAM2) provide prompt-based flexibility beyond methods with predefined categories, but face challenges in surgical scenarios due to the domain gap and limited long-term tracking. To address these limitations, we construct SA-SV, the largest surgical iVOS benchmark with instance-level spatio-temporal annotations (masklets) spanning eight procedure types (61k frames, 1.6k masklets), enabling comprehensive development and evaluation for long-term tracking and zero-shot generalization. Building on SA-SV, we propose SAM2S, a foundation model enhancing \textbf{SAM2} for \textbf{S}urgical iVOS through: (1) DiveMem, a trainable diverse memory mechanism for robust long-term tracking; (2) temporal semantic learning for instrument understanding; and (3) ambiguity-resilient learning to mitigate annotation inconsistencies across multi-source datasets. Extensive experiments demonstrate that fine-tuning on SA-SV enables substantial performance gains, with SAM2 improving by 12.99 average $\mathcal{J}$\&amp;$\mathcal{F}$ over vanilla SAM2. SAM2S further advances performance to 80.42 average $\mathcal{J}$\&amp;$\mathcal{F}$, surpassing vanilla and fine-tuned SAM2 by 17.10 and 4.11 points respectively, while maintaining 68 FPS real-time inference and strong zero-shot generalization. Code and dataset will be released at https://jinlab-imvr.github.io/SAM2S.</description>
      <guid isPermaLink="false">oai:arXiv.org:2511.16618v1</guid>
      <category>cs.CV</category>
      <category>eess.IV</category>
      <category>q-bio.TO</category>
      <pubDate>Fri, 21 Nov 2025 00:00:00 -0500</pubDate>
      <arxiv:announce_type>cross</arxiv:announce_type>
      <dc:rights>http://arxiv.org/licenses/nonexclusive-distrib/1.0/</dc:rights>
      <dc:creator>Haofeng Liu, Ziyue Wang, Sudhanshu Mishra, Mingqi Gao, Guanyi Qin, Chang Han Low, Alex Y. W. Kong, Yueming Jin</dc:creator>
    </item>
    <item>
      <title>Comparative in-silico study of drug release from intraocular implants for glaucoma treatment</title>
      <link>https://arxiv.org/abs/2410.01082</link>
      <description>arXiv:2410.01082v4 Announce Type: replace 
Abstract: Drug-releasing implants are gaining momentum in the treatment of glaucoma. However, they present several limitations, such as the inability to provide an even distribution of the drug in the trabecular meshwork. CFD simulations were used in this work to study the interplay between ocular fluid dynamics and drug diffusion to explore the options to achieve a homogeneous drug distribution in the target tissue. The analysis finds that thermal convective currents do not result in efficient mixing within the eye's anterior chamber. This results in highly localized drug delivery in the trabecular meshwork when using a gravity-placed cylindrical implant. Placing the implant in the posterior chamber results in improved mixing, although it presents the risk of therapeutical drugs being absorbed by the corneal endothelium instead of reaching the trabecular meshwork. Finally, a ring implant next to the trabecular meshwork is tested, which would give rise to a homogeneous concentration around the entirety of the trabecular meshwork. However, implanting a 360{\deg} ring with cylindrical cross-section next to the trabecular meshwork can entail significant surgical challenges, so the solution could consist of smaller cylindrical ring segments to attain a sufficient aqueous humour draining rate for each specific patient.</description>
      <guid isPermaLink="false">oai:arXiv.org:2410.01082v4</guid>
      <category>q-bio.TO</category>
      <pubDate>Fri, 21 Nov 2025 00:00:00 -0500</pubDate>
      <arxiv:announce_type>replace</arxiv:announce_type>
      <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
      <dc:creator>Umar Pitafi, Tao Chen, Cynthia Yu-Wai-Man, Daniel Sebastia-Saez</dc:creator>
    </item>
  </channel>
</rss>
